Rate of Detection and Antibiotic Resistance Pathogens of Purulent-Septic Infections in Cardiac Surgery Patients
https://doi.org/10.31631/2073-3046-2022-21-1-74-80
Abstract
Relevance. Among cardiac surgery hospital patients, purulent-septic infections (healthcare-associated infection or further HAI) do often occur. Aim of the work is to study the frequency of detection and antibiotic resistance of certain types of microorganisms in the development of HSI in operated patients of a cardiac surgery hospital. Materials and methods. The results of bacteriological examination of 213 operated patients with signs of HAI and 836 patients without signs of HAI were studied in a cardiac surgery hospital. The sensitivity of dominant microorganisms to antibiotics was determined. Results. Among patients operated in a cardiac surgery hospital Staphylcoccus epidermidis was more often extracted from the wound discharge, K. pneumoniae and fungi of the genus Candida were extracted from sputum, S. epidermidis and fungi of the genus Candida were extracted from blood, K. pneumoniae and Escherichia were extracted coli urine. These microorganisms were found among patients with signs of HAI significantly more often than among patients without signs of HAI. Among the dominant pathogens of HAI, a significant proportion of strains with multiple antibiotic resistance was identified, and among K. pneumoniae were found extremely resistant and pan-resistant clones producing extended-spectrum beta-lactamases. Conclusion. K. pneumoniae, S. epidermidis, E. coli and fungi of the genus Candida were the leading pathogens of HAI among patients operated in a cardiac surgery hospital. A significant number of bacterial strains with multiple antibiotic resistance have been identified.
About the Authors
V I SergevninRussian Federation
Viktor I. Sergevnin – Dr. Sci. (Med.), Professor of the Department of Epidemiology and Hygiene
26, st. Petropavlovskaya, Perm, 614026
+7 (912) 592-91-40
L G Kudryavtseva
Russian Federation
Larisa G. Kudryavtseva – Cand. Sci. (Med.), Head of the epidemiological department, doctor-epidemiologist
50–30, st. Borchaninov, Perm, 614064
+7 (919) 442-34-28
O G Pegyshina
Russian Federation
Оlga G. Pegyshina – bacteriologist
69–13, Karpinskiy str, Perm, 614022
+7 (919) 702-93-01
References
1. Alekyan B.G., Grigoryan A.M., Staferov A.V., Karapetyan N.G. X-ray diagnosis and treatment of heart and vascular diseases in the Russian Federation – 2017. Endovascular surgery. 2018; 2 (5): 93–240 (In Russ.). doi: 10.24183/2409-4080-2018-5-2-93-240
2. Bakhronov Sh.R. Development of endovascular methods of treatment of serious diseases of the human cardiovascular system and analysis of possible complications. Avicenna. 2018;21:32–41 (In Russ.).
3. Sergevnin VI, Kudryavtseva LG, Zolotukhina AI. Frequency and Risk Factors of Purulent Septic Infection among Adults after Different Types of an Open Heart Operations. Epidemiology and Vaccinal Prevention. 2020;19(5):34–40 (In Russ.). doi:10.31631/2073-3046-2020-19-5-34-40.
4. O’Keefe S, Williams K, Legare JF. Hospital-Acquired Infections After Cardiac Surgeryand Current Physician Practices: A Retrospective Cohort Study. JClinMedRes. 2017;9(1):10–16. doi:10.14740/joc-mr2637w
5. Takeshi Hatachi, Kazuya Tachibana, Yu Inata, et al. Risk Factors for Healthcare-Associated Infections After Pediatric Cardiac Surgery. Pediatric Critical Care Medicine. 2018;19(3):237–244. doi.org/10.1097/PCC.0000000000001445
6. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. HeartRhythm.2017; 14(12):e503–51. doi.org/10.1016/j.hrthm.2017.09.001
7. Sergevnin V. I., Kudryavtseva L .G.Сomparative assessment of the frequency and risk factors of purulent-septic infectionsin adult patients after various types of open and closed heart surger. Epidemiology and Infectious Diseases. 2020;25(2):78–87. doi.org/10.17816/EID34993 (In Russ.).
8. Aref’eva L. I., Gorskaya E. M., Savostyanova O. A., et al. Infectious complications of a bacterial nature in cardiovascular surgery. // Russian Medical Journal. 2013;3:36–42 (In Russ.).
9. Garс H, Cervantes-Luna B, Gonzalez-Cabello H, Miranda-Novales G. Risk factors for nosocomial infections after cardiac surgery in newborns with congenital heart disease. Pediatrics and Neonatology.2017;59(4):404–409. doi.org/10.1016/j.pedneo.2017.11.014
10. Allpress AL, Rosenthal GL, Goodrich KM, et al.Risk factors for surgical site infections after pediatric cardiovascular surgery // Pediatr Infect Dis J. 2004;23(3):231–4. doi.:10.1097/01.inf.0000114904.21616.ba
11. Sergevnin V. I., Kudryavtseva L. G., Pegyshina O. G.et al. Group Incidence by Purulent-Septic Infections of Clebsiellous Etiology in Cardiosurgical Patients. Epidemiology and Vaccinal Prevention. 2020;19(1):90–98. doi.org/10.31631/2073-3046-2020-19-1-90-98(In Russ.).
12. Cove ME, Spelman DW, Mac Laren G. Infectious Complications of Cardiac Surgery: A Clinical Review. Journal of Cardiothoracic and Vascular Anesthesia.2012;26(6):1094–1100.
13. Levy I, Ovadia B, Erez E, Rinat S, Ashkenazi S, Birk E, et al. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. JHospInfect. 2003;53(2):111–116. doi: 10.1053/jhin.2002.1359
14. European Centre for Disease Prevention and Control. Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals – protocol version 4.3. Stockholm: ECDC; 2012. Available at: https://www.ecdc.europa.eu/en/publications-data/point-prevalence-survey-healthcare-associated-infections-and-antimicrobial-use
15. Recommendations of the European Committee for the Determination of Antimicrobial Sensitivity (EUCAST) as amended in 2019 (EUCAST-2019) (In Russ.).
16. Magiorakos A P, SrinivasanA, CareyR B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infec. 2012;18(3):268–81. doi: 10.1111/j.1469-0691.2011.03570.x
17. SCAT (Antimicrobial Therapy Control Strategy) program for inpatient care. Russian clinical guidelines, ed. S.V. Yakovleva, N.I. Bricaud. S.V. Sidorenko, D.N. Protsenko. 2018: 26. (In Russ.).
Review
For citations:
Sergevnin V.I., Kudryavtseva L.G., Pegyshina O.G. Rate of Detection and Antibiotic Resistance Pathogens of Purulent-Septic Infections in Cardiac Surgery Patients. Epidemiology and Vaccinal Prevention. 2022;21(1):74-80. (In Russ.) https://doi.org/10.31631/2073-3046-2022-21-1-74-80